- Home
- MREO vs CMP Comparison
MREO vs CMP Comparison
Compare MREO & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | CMP |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 781.2M |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | MREO | CMP |
|---|---|---|
| Price | $2.13 | $19.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | $7.50 | ★ $19.67 |
| AVG Volume (30 Days) | ★ 2.2M | 499.5K |
| Earning Date | 11-10-2025 | 12-08-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $500,000.00 | ★ $1,243,900,000.00 |
| Revenue This Year | N/A | $4.83 |
| Revenue Next Year | $131.12 | $2.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.32 |
| 52 Week Low | $1.47 | $8.60 |
| 52 Week High | $3.90 | $22.69 |
Technical Indicators
Market Signals| Indicator | MREO | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 54.96 |
| Support Level | $2.02 | $16.77 |
| Resistance Level | $2.37 | $18.10 |
| Average True Range (ATR) | 0.15 | 1.13 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 61.11 | 50.69 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.